BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16114268)

  • 1. New insights in the mechanism by which SRIF influences GH secretion.
    Castaño JP; Delgado-Niebla E; Durán-Prado M; Luque RM; Sánchez-Hormigo A; Gracia-Navarro F; García-Navarro S; Kineman RD; Malagón MM
    J Endocrinol Invest; 2005; 28(5 Suppl):10-3. PubMed ID: 16114268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homologous and heterologous in vitro regulation of pig pituitary somatostatin receptor subtypes, sst1, sst2 and sst5 mRNA.
    Luque RM; Park S; Peng XD; Delgado E; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP
    J Mol Endocrinol; 2004 Apr; 32(2):437-48. PubMed ID: 15072550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortistatin mimics somatostatin by inducing a dual, dose-dependent stimulatory and inhibitory effect on growth hormone secretion in somatotropes.
    Luque RM; Peinado JR; Gracia-Navarro F; Broglio F; Ghigo E; Kineman RD; Malagón MM; Castaño JP
    J Mol Endocrinol; 2006 Jun; 36(3):547-56. PubMed ID: 16720722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the somatostatin receptor subtypes (sst) mediating the divergent, stimulatory/inhibitory actions of somatostatin on growth hormone secretion.
    Luque RM; Durán-Prado M; García-Navarro S; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP
    Endocrinology; 2006 Jun; 147(6):2902-8. PubMed ID: 16543371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
    Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD
    Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretagogues and the somatotrope: signaling and proliferation.
    Frohman LA; Kineman RD; Kamegai J; Park S; Teixeira LT; Coschigano KT; Kopchic JJ
    Recent Prog Horm Res; 2000; 55():269-90; discussion 290-1. PubMed ID: 11036941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin stimulates GH secretion in two porcine somatotrope subpopulations through a cAMP-dependent pathway.
    Ramírez JL; Gracia-Navarro F; García-Navarro S; Torronteras R; Malagón MM; Castaño JP
    Endocrinology; 2002 Mar; 143(3):889-97. PubMed ID: 11861510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin plays a dual, stimulatory/inhibitory role in the control of growth hormone secretion by two somatotrope subpopulations from porcine pituitary.
    Ramírez JL; Torronteras R; Castaño JP; Sánchez-Hormigo A; Garrido JC; García-Navarro S; Gracia-Navarro F
    J Neuroendocrinol; 1997 Nov; 9(11):841-8. PubMed ID: 9419835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the multifactorial control of growth hormone release by somatotropes: lessons from comparative endocrinology.
    Gahete MD; Durán-Prado M; Luque RM; Martínez-Fuentes AJ; Quintero A; Gutiérrez-Pascual E; Córdoba-Chacón J; Malagón MM; Gracia-Navarro F; Castaño JP
    Ann N Y Acad Sci; 2009 Apr; 1163():137-53. PubMed ID: 19456335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin at low doses stimulates growth hormone release from intact cultures of porcine pituitary cells.
    Ramírez JL; Castaño JP; Gracia-Navarro F
    Horm Metab Res; 1998 Apr; 30(4):175-7. PubMed ID: 9623629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential contribution of nitric oxide and cGMP to the stimulatory effects of growth hormone-releasing hormone and low-concentration somatostatin on growth hormone release from somatotrophs.
    Luque RM; Rodríguez-Pacheco F; Tena-Sempere M; Gracia-Navarro F; Malagón MM; Castaño JP
    J Neuroendocrinol; 2005 Sep; 17(9):577-82. PubMed ID: 16101896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of ghrelin signaling pathways with the GH neuroendocrine axis: a new and experimentally tested model.
    Wagner C; Caplan SR; Tannenbaum GS
    J Mol Endocrinol; 2009 Sep; 43(3):105-19. PubMed ID: 19433492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of somatostatin receptor subtypes in membrane ion channel modification by somatostatin in pituitary somatotropes.
    Yang SK; Chen C
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1221-7. PubMed ID: 17892506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine control of growth hormone in fish.
    Canosa LF; Chang JP; Peter RE
    Gen Comp Endocrinol; 2007 Mar; 151(1):1-26. PubMed ID: 17286975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin increases growth hormone (GH) secretion in a subpopulation of porcine somatotropes: evidence for functional and morphological heterogeneity among porcine GH-producing cells.
    Castaño JP; Torronteras R; Ramirez JL; Gribouval A; Sanchez-Hormigo A; Ruiz-Navarro A; Gracia-Navarro F
    Endocrinology; 1996 Jan; 137(1):129-36. PubMed ID: 8536603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiology of ghrelin and related peptides.
    Anderson LL; Jeftinija S; Scanes CG; Stromer MH; Lee JS; Jeftinija K; Glavaski-Joksimovic A
    Domest Anim Endocrinol; 2005 Jul; 29(1):111-44. PubMed ID: 15927771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile.
    Bruns C; Lewis I; Briner U; Meno-Tetang G; Weckbecker G
    Eur J Endocrinol; 2002 May; 146(5):707-16. PubMed ID: 11980628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ghrelin induces growth hormone secretion via a nitric oxide/cGMP signalling pathway.
    Rodríguez-Pacheco F; Luque RM; Tena-Sempere M; Malagón MM; Castaño JP
    J Neuroendocrinol; 2008 Mar; 20(3):406-12. PubMed ID: 18208548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New SRIF analogs in the control of human pituitary adenomas: perspectives.
    Jaquet P; Saveanu A; Barlier A
    J Endocrinol Invest; 2005; 28(5 Suppl):14-8. PubMed ID: 16114269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.